Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Millions of people are to be given access to digital treatment for insomnia as an alternative to sleeping pills. Study by Colin Espie et al shows that Sleepio improves wellbeing in nearly three quarters of participants.

Apply by 10 March for 2017/18 for a PGDip or MSc. The course is also available as CPD modules. It is hosted by the Sleep and Circadian Neuroscience Institute (SCNi) in our Department. © Shutterstock

The Sleepio app – a cognitive behavioural therapy based programme which can be accessed via smartphone or web - is to be made available initially in Berkshire, Buckinghamshire and Oxfordshire later this month before being rolled out across other areas in the South East in early 2019. It is the first NHS rollout of direct-access digital medicine - fully automated, self-help programmes, easily accessible via app or web.

We are delighted to see this important research be so rapidly translated to the NHS for clinical benefit. The recognition that sleep is of fundamental importance for our well-being and clinical health is growing and studies such as these that help us understand and tackle current issues we face as a society regarding sleep deficit are vital.

- Professor Irene Tracey, Head of the Nuffield Department of Clinical Neurosciences

Sleepio works by helping people to resolve their persistent sleep problems by discovering their ideal personal sleep pattern, and by overcoming the 'racing mind' that so often prevents people from sleeping. The announcement comes as the largest research trial into the impact of digital cognitive behavioural therapy (dCBT) on adults with insomnia demonstrated the link between better sleep and improved overall health. Published in the latest JAMA Psychiatry, the Oxford University led 12-month UK study showed that dCBT based intervention Sleepio improved overall wellbeing, mental health and quality of life.

The South East NHS roll-out of the Sleepio programme is designed to find the best ways of helping people to access digital medicine through partnering with stakeholders such as GPs, pharmacies, libraries and local employers. It will develop a blueprint for wider uptake of digital medicine across the NHS in England in a bid to improve sleep health whilst reducing the current over-reliance on medication, which is used to treat the estimated 20% of working adults that suffer from chronic sleeplessness.

Clinical guidelines recommend the psychological approach known as cognitive behavioural therapy (CBT) for insomnia. However, treatment is currently dominated by medication, which can have unpleasant or harmful side effects. Last year, over 12 million prescriptions for insomnia were written, at a cost to the NHS of £72m - 1 prescription for every GP, every day of the year*. On the other hand Sleepio which is digital CBT has been shown in clinical trials to help over three quarters of insomnia sufferers achieve normal sleep.

'Sleep ranks with air, water and food as one of the essentials of life, yet 10% to 12% of the population don’t get enough of it due to insomnia,' said study lead author Colin Espie, Oxford University Professor of Sleep Medicine and Chief Medical Officer of Big Health. 'Furthermore, most people who seek help with insomnia do so because of its negative impact on their daytime quality of life. Our study suggests that this new form of digital medicine could be a powerful way to help millions of people not just sleep better, but achieve better mental and physical well-being as a result.' This research was supported by the National Institute for Health Research Oxford Biomedical Research Centre.

Sleepio is one of the first digital health applications ever to be reviewed by NICE, and has been supported by the NHS Innovation Accelerator since 2015. Sleepio has now been tested in eight clinical trials, including the largest ever trial of a psychological intervention, significantly improving both sleep and mental health outcomes (Freeman et al. 2017).

Similar stories

Accidental awareness in obstetric surgery under general anaesthesia more frequent than expected

Anaesthetics Research

The largest ever study of awareness during obstetric general anaesthesia shows around 1 in 250 women may be affected, and some may experience long-term psychological harm.

Two neurologists awarded MRC Senior Clinical Fellowships

Clinical Neurology Research

Two of our Associate Professors, Sarosh Irani and George Tofaris, have been awarded MRC Senior Clinical Fellowships.

Developing diagnostics for COVID-19

Clinical Neurology Coronavirus Research

Associate Professor Sarosh Irani, who heads up our Autoimmune Neurology Group, has been funded by Mologic to help develop diagnostics for COVID-19.

COVID-19 and Guillain-Barré syndrome

Clinical Neurology Coronavirus Research

Multiple recent case reports have suggested a link between COVID-19 and Guillain-Barré syndrome (GBS), an acute, disabling, immune-mediated disorder of the peripheral nervous system. It is currently unclear whether this simply represents a chance association.

The brain understands relationships in the same way as it understands how to move in space

Integrative Neuroimaging Research

Researchers led by a team at the Wellcome Centre for Integrative Neuroimaging at the University of Oxford have developed a new framework that binds together the way the brain forms maps of space to the way the brain understands relationships of any kind – general mental maps.